SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cody JD, Singer FR, Roodman GD, Otterund B, Lewis TB, Leppert M, Leach RJ 1997 Genetic linkage of Paget disease of the bone to chromosome 18q. Am J Hum Genet 61:11171122.
  • 2
    Haslam SI, Van Hul W, Morales-Piga A, Balemans W, San-Millan JL, Nakatsuka K, Willems P, Haites NE, Ralston SH 1998 Paget's disease of bone: Evidence for a susceptibility locus on chromosome 18q and for genetic heterogeneity. J Bone Miner Res 13:911917.
  • 3
    Hocking LJ, Herbert CA, Nicholls RK, Williams F, Bennett ST, Cundy T, Nicholson GC, Wuyts W, Van Hul W, Ralston SH 2001 Genome-wide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet 69:10551061.
  • 4
    Laurin N, Brown JP, Lemainque A, Duchesne A, Huot D, Lacourciere Y, Drapeau G, Verreault J, Raymond V, Morissette J 2001 Paget disease of bone: Mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet 69:528543.
  • 5
    Good DA, Busfield F, Fletcher BH, Duffy DL, Kesting JB, Andersen J, Shaw JT 2002 Linkage of Paget disease of bone to a novel region on human chromosome 18q23. Am J Hum Genet 70:517525.
  • 6
    Laurin N, Brown JP, Morissette J, Raymond V 2002 Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:15821588.
  • 7
    Harvey L, Gray T, Beneton MN, Douglas DL, Kanis JA, Russell RG 1982 Ultrastructural features of the osteoclasts from Paget's disease of bone in relation to a viral etiology. J Clin Pathol 35:771779.
  • 8
    Mills BG, Singer FR, Weiner LP, Suffin SC, Stabile E, Holst P 1984 Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop 183:303311.
  • 9
    Basle MF, Fournier JG, Rozenblatt S, Rebel A, Bouteille M 1986 Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67:907913.
  • 10
    Reddy SV, Singer FR, Roodman GD 1995 Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 80:21082111.
  • 11
    Gordon MT, Mee AP, Anderson DC, Sharpe PT 1995 Canine bone marrow cultures infected with canine distemper virus: An in vitro model of Paget's disease. Bone 19:S461S466.
  • 12
    Birch MA, Taylor W, Fraser WD, Ralston SH, Hart CA, Gallagher JA 1994 Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone. J Bone Miner Res 9:1116.
  • 13
    Helfrich MH, Hobson RP, Grabowski PS, Zurbriggen A, Cosby SL, Dickson GR, Fraser WD, Ooi CG, Selby PL, Crisp AJ, Wallace RG, Kahn S, Ralston SH 2000 A negative search for a paramyxoviral etiology of Paget's disease of bone: Molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res 15:23152329.
  • 14
    Kurihara N, Reddy SV, Menaa C, Anderson D, Roodman GD 2000 Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest 105:607614.
  • 15
    Menaa C, Barsony J, Reddy SV, Cornish J, Cundy T, Roodman GD 2000 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease. J Bone Miner Res 15:228236.
  • 16
    Kurihara N, Reddy SV, Araki N, Ishizuka S, Ozono K, Cornish J, Cundy T, Singer FR, Roodman GD 2004 Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease. J Bone Miner Res 19:11541164.
  • 17
    Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Smith JF, Singer FR 1992 Interleukin-6: A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89:4652.
  • 18
    Dorig RE, Marcil A, Chopra A, Richardson CD 1993 The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295305.
  • 19
    Reddy SV, Kurihara N, Menaa C, Landucci G, Forthal D, Koop BA, Windle JJ, Roodman GD 2001 Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts. Endocrinology 142:28982905.
  • 20
    Friedrichs WE, Reddy SV, Bruder JM, Cundy T, Cornish J, Singer FR, Roodman GD 2002 Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 17:145151.
  • 21
    Rima BK, Earle JA, Yeo RP, Herlihy L, Baczko K, ter Meulen V, Carabana J, Caballero M, Celma ML, Fernandez-Munoz R 1995 Temporal and geographical distribution of measles virus genotypes. J Gen Virol 76:11731180.
  • 22
    Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA 2001 Comparison of predicted amino acid sequences of measles virus strains in the Edmonston Vaccine Lineage. J Virol 75:910920.
  • 23
    Reddy SV, Scarcez T, Windle JJ, Leach RJ, Hundley JE, Chirgwin JM, Chou JY, Roodman GD 1993 Cloning and characterization of the 5′-flanking region of the mouse tartrate-resistant acid phosphatase gene. J Bone Miner Res 8:12631270.
  • 24
    Reddy SV, Hundley JE, Windle JJ, Alcantara O, Linn R, Leach RJ, Boldt DH, Roodman GD 1995 Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J Bone Miner Res 10:601606.
  • 25
    Nagy A, Gertsenstein M, Vintersten K, Behringer R 2003 Manipulating the Mouse Embryo: A Laboratory Manual, 3rd ed, CSHL Press, Cold Spring Harbor, NY, USA.
  • 26
    Hentunen TA, Jackson SH, Chung H, Reddy SV, Lorenzo J, Choi SJ, Roodman GD 1999 Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen. Endocrinology 140:29542961.
  • 27
    Liu B, Yu SF, Li TJ 2003 Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med 32:367375.
  • 28
    American Society for Bone and Mineral Research President's Committee on Nomenclature 2000 Proposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. J Bone Miner Res 15:22932296.
  • 29
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595610.
  • 30
    Hentunen TA, Reddy SV, Boyce BF, Devlin R, Park HR, Chung H, Selander KS, Dallas M, Kurihara N, Galson DL, Goldring SR, Koop BA, Windle JJ, Roodman GD 1998 Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest 102:8897.
  • 31
    Chiu WS, McManus JF, Notini AJ, Cassady AI, Zajac JD, Davey RA 2004 Transgenic mice that express Cre recombinase in osteoclasts. Genesis 39:178185.
  • 32
    Neale SD, Smith R, Wass JA, Athanasou NA 2000 Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D3 and RANKL. Bone 27:409416.
  • 33
    Menaa C, Reddy SV, Kurihara N, Maeda H, Anderson D, Cundy T, Cornish J, Singer FR, Bruder JM, Roodman GD 2000 Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest 105:18331838.
  • 34
    Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A 2001 Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:10931102.
  • 35
    O'Brien CA, Jilka RL, Fu Q, Stewart S, Weinstein RS, Manolagas SC 2005 IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab 289:784793.
  • 36
    Lotinun S, Sibonga JD, Turner RT 2005 Evidence that the cells responsible for marrow fibrosis in a rat model for hyperparathyroidism (HPT) are preosteoblasts. Endocrinology 146:40744081.
  • 37
    Wronski TJ, Li M 1998 PTH: Skeletal effects in the ovariectomized rat model for postmenopausal bone loss. In: WhitfieldJF, MorleyP (eds.) Anabolic Treatment for Osteoporosis. CRC Press, New York, NY, USA, pp. 5981.
  • 38
    Jee WS, Ma YF 1997 The in vivo anabolic actions of prostaglandins in bone. Bone 21:297304.
  • 39
    Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE 1996 Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228231.
  • 40
    Servet-Delprat C, Vidalain PO, Valentin H, Rabourdin-Combe C 2003 Measles virus and dendritic cell functions: How specific response cohabits with immunosuppression. Curr Top Microbiol Immunol 276:103123.
  • 41
    Schneider-Schaulies J, Schneider-Schaulies S, Ter Meulen V 1993 Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology 195:219228.